Compare SUPN & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUPN | CPK |
|---|---|---|
| Founded | 2005 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.1B |
| IPO Year | 2010 | 1995 |
| Metric | SUPN | CPK |
|---|---|---|
| Price | $49.07 | $124.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $61.60 | ★ $140.00 |
| AVG Volume (30 Days) | ★ 442.4K | 117.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.16% |
| EPS Growth | N/A | ★ 13.50 |
| EPS | N/A | ★ 5.97 |
| Revenue | $392,755,000.00 | ★ $930,000,000.00 |
| Revenue This Year | $22.70 | $8.39 |
| Revenue Next Year | $19.14 | $5.36 |
| P/E Ratio | ★ N/A | $21.23 |
| Revenue Growth | N/A | ★ 18.14 |
| 52 Week Low | $29.16 | $115.24 |
| 52 Week High | $59.68 | $140.59 |
| Indicator | SUPN | CPK |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 39.07 |
| Support Level | $47.43 | $123.08 |
| Resistance Level | $52.25 | $126.05 |
| Average True Range (ATR) | 1.52 | 2.73 |
| MACD | -0.02 | -0.30 |
| Stochastic Oscillator | 16.59 | 2.06 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by PSC. Eastern Shore, its natural gas transmission is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.